The journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. Every effort
will be made to notify authors about acceptance or rejection within 4 to 6 weeks. Book Reviews, Letters to the Editor and Abstracts of
articles will be published at the Editors' discretion. Categories of manuscripts include:
(1) Full-length Papers: giving findings
of original basic or clinical research in any area of epilepsy within the scope of the journal.
(2) Short Communications: such as
brief reports of research results which have reached a stage where they are ready for preliminary communication, or case reports of special
relevance. Short communications will be published in the next available issue. They should not be more than 1500 words, or equivalent
space including tables and figures.
(3) Review Articles: on specialised topics within the scope of the journal. Prospective authors
should contact one of the Managing Editors beforehand.
Submission of Manuscripts
Epilepsy Research proceeds
totally online via an electronic submission system. By accessing the online submission system at http://ees.elsevier.com/epires/
you will be guided stepwise through the creation and uploading of the various files. It is suggested that authors direct the manuscripts
to the most appropriate Co-Editor-in-Chief. There is a section for Editor Comments where authors are invited to direct comments to the
editors or suggest possible reviewers (please also provide e-mail adresses) for their paper. When submitting a manuscript online, authors
need to provide an electronic version of their manuscript and any accompanying figures and tables.
The author should select from
a list of scientific classifications, which will be used to help the editors select reviewers with appropriate expertise, and an article
type for their manuscript (Full-Length Papers, Short Communications, Review Articles). Once the uploading is done, the system automatically
generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision and request
for revisions, will be processed through the system and will reach the corresponding author by e-mail.
Once a manuscript has successfully
been submitted via the online submission system authors may track the status of their manuscript using the online submission system (details
will be provided by e-mail). If your manuscript is accepted by the journal, subsequent tracking facilities are available on Elsevier's
Author Gateway, using the unique reference number provided by Elsevier and corresponding author name (details will be provided by e-mail).
Authors may send queries concerning the submission process or journal procedures to the appropriate co-Editor-in-Chief:
Basic
research:
Dr. Asla Pitkanen, MD, PhD,
Department of Neurobiology, Professor and Chair,
A.I.Virtanen Institute for Molecular
Sciences, University of Kuopio,
P.O.Box 1627, Street address: Neulaniementie 2,
FIN-70 211 Kuopio, FINLAND,
e-mail: asla.pitkanen@uku.fi
Clinical research:
Dr. William H. Theodore, MD
6328 Lenox road
Bethesda MD 20817, USA
e-mail: william_theodore@hotmail.com
For further details on how to submit online, please refer to the EES Tutorial for authors or contact Elsevier's Author Support Team
at authorsupport@elsevier.com
Manuscript submission requirements
Manuscripts submitted to the Journal
are only accepted on the understanding that:
1. they deal with original research and are subject to editorial revision;
2. they
have not been and will not be published in whole or in part in any other journal;
3. the recommendations from the Declaration of
Helsinki and the internationally accepted principles in the care and use of experimental animals have been adhered to;
4. the cover
letter should attest that the proper institutional approval was obtained;
5. that the cover letter clearly discloses any actual or
potential financial and other conflict of interest related to the submitted manuscript. This requirement applies to authors and co-authors
and includes disclosure of all financial considerations (ownership, equity position, stock options, consulting fees, patent rights, employee
status and corporate affiliations) associated with any drug, product, process, or commercial laboratory mentioned in the submitted material.
In addition, the general details of support from sources for the study should be described. Failure to comply with conflict of interest
requirements may result in rejection of the manuscript and retraction of the published article.
Submission of a manuscript implies
the transmission of copyright from the author to the Publisher.
Preparation of manuscript
1. Papers should be written
in English and should be concisely written in a readily understandable style.
2. Standard nomenclature should be used throughout;
unfamiliar or new terms and arbitrary abbreviations should be defined when first used.
3. Unnecessary abbreviations and 'slang' are
to be avoided.
4. A title page which includes only the title, authors' full names, complete addresses of academic or professional
affiliations, fax and e-mail details; the author to whom proofs and correspondence should be addressed should be indicated by an asterisk.
The title should be short, clear and concise and should indicate the major point of the paper.
5. An abstract of about 200 words
for Full-length Papers and 50-70 words for Short Communications, The abstract should state briefly the purpose of the research, the principal
results and major conclusions. An abstract is often presented separate from the article, so it must be able to stand-alone.
6. Up
to six keywords should be given for indexing.
7. Subdivision of the article. Divide your article into clearly defined and numbered
sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2,), 1.2, etc. (the abstract is not included in section numbering). Use
this numbering also for internal cross-referencing: do not just refer to 'the text.' Any subsection may be given a brief heading. Each
heading should appear on its own separate line.
8. Tables are to be uploaded, numbered consecutively with Arabic numbers. Each table
should include a header. Do not use vertical bars. For every variable, the units of measurement should be clearly identified.
9.
Figures of good quality should be submitted online as a separate file and numbered consecutively with Arabic numbers. Please use a lettering
that remains clearly readable even after reduction to about 66%. For every figure, a legend should be provided. Please refer to the generic
Elsevier artwork instructions: http://authors.elsevier.com/locate/artwork
Structure of manuscript
1. Introduction:This should be complete enough to give the reasons for undertaking the study and a summary of the experimental
plan. Exhaustive reviews of the literature should be avoided.
2. Methods: These should be described in sufficient detail so
that the work can be duplicated, or by reference to previous descriptions if they are readily available. Commonly used methods require
only a citation of the original source unless they have been substantially modified. Statistical tests used for evaluation of data should
be briefly explained. In case of experimental studies, animals used should be described, including information on breed, breeder, sex,
age, weight and the maintenance conditions. Special chemicals and drugs with their source should be grouped under a separate sub-heading
('Materials' or 'Drugs'). For drugs, generic names should be used: trade names may be given in parenthesis where the drug is first mentioned.
In case of new drugs, a detailed chemical description (formula) should be given. The form of the drug used should be indicated.
3. Results: In this section the findings should be described clearly, concisely, and in logical order without discussion of their
significance. Only in the case of Short Communications, the Results and Discussion section may be combined. Results should usually be
presented in graphic or tabular form, rather than discursively. There should be no duplication in text, tables and figures. Experimental
conclusions should be based on adequate numbers of observations with statistical analysis of variance and the significance of differences.
The number of individual values represented by a mean should be indicated.
4. Discussion: This section should present conclusions
to be drawn from the results accompanied by an assessment of their significance in relation to previous work. Speculative discussion
is not discouraged, but the speculation should be based on the data presented and identified as such. In general, the discussion should
be as concise as possible.
5. Acknowledgements: These may be included at the end of the Discussion section under a separate
heading (but no number).
6. References: Citation of literature references in the text should be given at the appropriate places
by author(s) name(s) followed by the year in chronological order (Strunk and White, 1975; Gurman and Kniskern, 1981). With more than
two authors, name only the first followed by "et al."(Paivio et al., 1975). When two or more papers by the same author(s) appear in one
year, distinguish them by a, b, etc. after the date (Babb et al., 1984a,b). The author is responsible for accurate reference citation
and the exact agreement between text and reference list. All references cited in the text should be listed at the end of the paper on
a separate page (also double-spaced), arranged in alphabetical order of the first author's names. Two or more references to the same
author(s) should be in chronological order, according to the Harvard system. For references with three or more authors, which should
be referred to as "et al." in the text, all names should be given in the reference list and these references should be arranged chronologically.
Journal titles should be abbreviated according to Index Medicus. The form of literature reference should conform to the examples given
below.
Paivio, A., Jansen, B., Becker, L.J., 1975. Comparisons through the mind's eye. Cognition 37, 635-647.
Strunk Jr., W.,
White, E.B., 1979. The Elements of Style, 3rd Ed. Macmillan, New York.
Gurman, A.S., Kniskern, D.P. (Eds.), Handbook of Family Therapy.
Brunner/Maazel, New York, pp. 742-775.
This journal should be cited in lists of references as Epilepsy Res.
Copyright
Transfer
Upon acceptance of an article, you will be asked to transfer copyright (for more information on copyright, see http://authors.elsevier.com/locate/authorsrights.
This transfer will ensure the widest possible dissemination of information. If excerpts from other copyrighted works are included in
the submission, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier
has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Philadelphia, PA, USA: phone (+1) 215 238
7869, fax (+1) 215 238 2239, e-mail: healthpermissions@elsevier.com.
Requests for materials from other Elsevier publications
may also be completed on-line via the Elsevier homepage http://www.elsevier.com/locate/permissions
Funding bodies
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles
appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their
grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies
Proofs
Authors should keep a copy of their manuscripts, as proofs will be sent to them without the manuscript. One set
of page proofs in PDF format will be sent by e-mail to the corresponding author, to be checked for typesetting/editing. No changes in,
or additions to, the accepted (and subsequently edited) manuscript will be allowed at this stage. Proofreading is solely your responsibility.
A form with queries from the copyeditor may accompany your proofs. Please answer all queries and make any corrections or additions required.
Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible. In order to do
this we need your help. When you receive the (PDF) proof of your article for correction, it is important to ensure that all of your corrections
are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your first sending is complete.
Note that this does not mean you have any less time to make your corrections, just that only one set of corrections will be accepted.
Reprints
A total of 25 reprints of each paper will be provided free of charge to the author(s). Additional copies
can be ordered at prices shown on a price list, which will be sent to the authors with the proofs.
Page Charges
There
are no page charges.
Author enquiries
For enquiries relating to the submission of articles please visit Elsevier's
Author Gateway at http://www.elsevier.com/locate/authors. The Author Gateway also provides the facility to track accepted
articles and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright
information, frequently asked questions and more. |
